The Global Pharmaceutical Contract Research & Manufacturing (CRAM) Market 2019-2023 – Projected to Register a CAGR of More Than 9% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Pharmaceutical Contract Research and Manufacturing (CRAM) Market
2019-2023” report has been added to ResearchAndMarkets.com’s
offering.

The pharmaceutical contract research and manufacturing (CRAM) market
will register a CAGR of more than 9% by 2023.

The significant advances in their healthcare infrastructure and
technological advances in their drug development processes. As a result,
large and medium-sized pharmaceutical companies from developed countries
are outsourcing the research and manufacturing operations of various
drugs and therapies to the vendors in such countries. Factors such as
the increasing number of US FDA-approved manufacturing plants in such
countries also encourage outsourcing.

The rapidly evolving market environment and the strong support of the
Government of China help the country specialize in the research of
drugs, including regenerative medicines and small-molecule based drugs.
Therefore, the global pharmaceutical CRAM market is expected to grow
strongly during the forecast period.

Growing need to focus on core competencies

One of the growing changes in the global pharmaceutical market is the
increasing volume of outsourcing of partial or complete research and
manufacturing processes to CROs and CMOs. This is primarily due to the
rising focus of the sourcing companies on developing therapies for large
indications such as oncology, neurology, and autoimmune disorders.

Stereotypical nature of CMOs

Despite the growing popularity of CMOs in emerging countries such as
China and India, the global pharmaceutical CRAM market faces a major
challenge from the limited offerings of the CMOs. This is currently a
major challenge faced by CMOs, which is expected to significantly hinder
the growth of the global pharmaceutical CRAM market during the forecast
period.

Competitive Landscape

The market appears to be moderately concentrated and with the presence
of limited vendors. This market research report will help clients
identify new growth opportunities and design unique growth strategies by
providing a comprehensive analysis of the market’s competitive landscape
and offering information on the products offered by companies.

Key Players

• Boehringer Ingelheim International GmbH
• Catalent Inc.
• IQVIA
• Lonza
• Thermo Fisher Scientific Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY SERVICE

• Comparison by service
• CMO – Market size and forecast 2018-2023
• CRO – Market size and forecast 2018-2023
• Market opportunity by service

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• RoW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• IQVIA
• Lonza
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3qvbx5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Discovery, Pharmaceutical
Manufacturing